Quadrant Capital Group LLC Pfizer Inc Transaction History

Quadrant Capital Group LLC

$1.43 Billion
Q4 2024

A detailed history of Quadrant Capital Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 42,974 shares of PFE stock, worth $1.09 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

42,974

Previous 58,303 26.29%

Holding current value

$1.09 Million

Previous $1.69 Million 32.42%

% of portfolio

0.08%

Previous 0.12%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$24.8 - $30.19 $380,159 - $462,782	-15,329 Reduced 26.29%	42,974 $1.14 Million
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $33,904 - $38,421	-1,224 Reduced 2.06%	58,303 $1.69 Million
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $268,033 - $314,085	10,611 Added 21.69%	59,527 $1.67 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $302,913 - $347,841	-11,700 Reduced 19.3%	48,916 $1.36 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $169,348 - $219,965	-6,481 Reduced 9.66%	60,616 $1.75 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $76,855 - $89,836	-2,395 Reduced 3.45%	67,097 $2.23 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $3,323 - $3,844	-92 Reduced 0.13%	69,492 $2.55 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $169,692 - $220,914	-4,308 Reduced 5.83%	69,584 $2.84 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $408,565 - $533,337	9,786 Added 15.27%	73,892 $3.79 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $25,774 - $31,464	-589 Reduced 0.91%	64,106 $2.81 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $106,925 - $126,780	-2,298 Reduced 3.43%	64,695 $3.39 Million
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $86,193 - $106,803	1,884 Added 2.89%	66,993 $3.47 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $705,167 - $1.05 Million	17,066 Added 35.52%	65,109 $3.85 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $217,209 - $279,024	5,534 Added 13.02%	48,043 $2.07 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $15,225 - $17,248	-424 Reduced 0.99%	42,509 $1.67 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $115,507 - $130,268	3,449 Added 8.74%	42,933 $1.56 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $126,315 - $160,621	3,774 Added 10.57%	39,484 $1.45 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $417,195 - $489,465	-13,140 Reduced 26.9%	35,710 $1.31 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $100,630 - $122,080	3,341 Added 7.34%	48,850 $1.6 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $495,486 - $707,943	-18,331 Reduced 28.71%	45,509 $1.49 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $228,662 - $259,502	6,946 Added 12.21%	63,840 $2.47 Million
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $243,122 - $315,258	-7,483 Reduced 11.62%	56,894 $2.03 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $57,910 - $65,020	1,566 Added 2.49%	64,377 $2.77 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $397,687 - $436,926	10,605 Added 20.31%	62,811 $2.65 Million
Q4 2018 Jan 17, 2019	SELL	$38.47 - $43.86 $79,017 - $90,088	-2,054 Reduced 3.79%	52,206 $2.26 Million
Q3 2018 Oct 29, 2018	BUY	$34.47 - $41.81 $1,413 - $1,714	41 Added 0.08%	54,260 $2.37 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $11,839 - $12,622	359 Added 0.67%	54,219 $1.94 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $174,196 - $202,092	5,459 Added 11.28%	53,860 $1.89 Million
Q4 2017 Jan 31, 2018	BUY	$33.26 - $35.29 $41,042 - $43,547	1,234 Added 2.62%	48,401 $1.74 Million
Q3 2017 Oct 13, 2017	BUY	$31.0 - $34.15 $18,166 - $20,011	586 Added 1.26%	47,167 $1.66 Million
Q2 2017 Aug 15, 2017	BUY	N/A	46,581	46,581 $1.5 Million

Others Institutions Holding PFE

# of Institutions

3,378

Shares Held

3.56B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $142B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Pfizer Inc Transaction History